About Hospital de Braga
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
7
Hoffmann-La Roche
7
Janssen Research & Development, LLC
6
Takeda
5
Biogen
4
Boehringer Ingelheim
4
Ipsen
3
Pfizer
3
Shire
3
Arena Pharmaceuticals
2
Daiichi Sankyo, Inc.
2
Clinical Trials at Hospital de Braga
During the past decade, Hospital de Braga conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 29 clinical trials were completed, i.e. on
average, 45.3% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 18 clinical trials were completed. i.e. 69.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
2011-09-01
2017-10-01
Terminated
67
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
2013-01-07
2022-05-13
Completed
559
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
2014-01-30
2024-10-04
Active, not recruiting
50
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
2014-02-24
2020-06-27
Completed
707
MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing
2013-12-01
2021-05-30
Terminated
5,850
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
2014-12-24
2020-06-23
Completed
397
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital de Braga" #1 sponsor was "Celgene" with 7 trials, followed by "Hoffmann-La Roche" with 7 trials
sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Takeda" with 5 trials sponsored and "Biogen"
with 5 trials sponsored. Other sponsors include 42 different institutions and
companies that sponsored additional 36 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Braga"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Clinical Academic Center (2CA-Braga)" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were
collaborators in the rest 18 trials.
Clinical Trials Conditions at Hospital de Braga
According to Clinical.Site data, the most researched conditions in "Hospital de Braga" are
"Ulcerative Colitis" (8 trials), "Crohn's Disease" (5 trials), "Multiple Sclerosis" (5 trials), "Alzheimer's Disease" (3 trials) and "Depressive Disorder, Major" (3 trials). Many other conditions were trialed in "Hospital de Braga" in a lesser frequency.
Clinical Trials Intervention Types at Hospital de Braga
Most popular intervention types in "Hospital de Braga" are "Drug" (67 trials), "Other" (7 trials), "Biological" (6 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (33 trials), "Docetaxel" (3 trials), "GED-0301" (3 trials), "Paclitaxel" (3 trials) and "Aticaprant" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital de Braga
The vast majority of trials in "Hospital de Braga" are
74 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Hospital de Braga
Currently, there are 35 active trials in "Hospital de Braga".
1 are not yet recruiting,
19 are recruiting,
14 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 31 completed trials in Hospital de Braga,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital de Braga, 2 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 53 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 6 trials that are defined as “Not Applicable".